We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
Cap. Flow
+$1B
Cap. Flow %
7.59%
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$120M
2
GL icon
Globe Life
GL
+$115M
3
MPT
Medical Properties Trust
MPT
+$91.5M
4
ACGL icon
Arch Capital
ACGL
+$69.2M
5
AMZN icon
Amazon
AMZN
+$45.6M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$138M
2
GSK icon
GSK
GSK
+$98.7M
3
CCK icon
Crown Holdings
CCK
+$92.3M
4
AWK icon
American Water Works
AWK
+$54M
5
SEDG icon
SolarEdge
SEDG
+$45.7M

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Financials 15.05%
3 Healthcare 13.07%
4 Consumer Discretionary 9.61%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROBT icon
1176
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$777M
$211K ﹤0.01%
4,207
+4
+0.1% +$177
BST icon
1177
BlackRock Science and Technology Trust
BST
$1.71B
$210K ﹤0.01%
3,987
+9
+0.2% +$423
EWS icon
1178
iShares MSCI Singapore ETF
EWS
$1.15B
$210K ﹤0.01%
9,820
– –
RETA
1179
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$210K ﹤0.01%
1,700
-43
-2% -$5.65K
AXS icon
1180
AXIS Capital
AXS
$7.49B
$209K ﹤0.01%
4,150
– –
DNLI icon
1181
Denali Therapeutics
DNLI
$3.97B
$209K ﹤0.01%
2,500
– –
IEV icon
1182
iShares Europe ETF
IEV
$1.7B
$207K ﹤0.01%
4,330
– –
MGU
1183
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
$207K ﹤0.01%
10,250
+3
+0% +$58
DXJ icon
1184
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
$206K ﹤0.01%
3,796
+777
+26% +$40.1K
PGF icon
1185
Invesco Financial Preferred ETF
PGF
$669M
$205K ﹤0.01%
10,684
+4,572
+75% +$86.8K
SBIO icon
1186
ALPS Medical Breakthroughs ETF
SBIO
$215M
$204K ﹤0.01%
4,000
– –
WSM icon
1187
Williams-Sonoma
WSM
$29.6B
$204K ﹤0.01%
4,028
+82
+2% +$4.2K
ANEW icon
1188
ProShares MSCI Transformational Changes ETF
ANEW
$8.05M
$202K ﹤0.01%
+4,800
New +$192K
CELL
1189
DELISTED
PhenomeX Inc. Common Stock
CELL
$201K ﹤0.01%
2,254
– –
MRCC
1190
DELISTED
Monroe Capital Corp
MRCC
$200K ﹤0.01%
24,985
-5,460
-18% -$42K
VONE icon
1191
Vanguard Russell 1000 ETF
VONE
$8.69B
$200K ﹤0.01%
1,146
– –
FINX icon
1192
Global X FinTech ETF
FINX
$165M
$199K ﹤0.01%
4,276
-12
-0.3% -$501
IAT icon
1193
iShares US Regional Banks ETF
IAT
$678M
$199K ﹤0.01%
4,401
+4,210
+2,204% +$170K
ICF icon
1194
iShares Select U.S. REIT ETF
ICF
$2.08B
$199K ﹤0.01%
3,706
+18
+0.5% +$953
NCV
1195
Virtus Convertible & Income Fund
NCV
$391M
$199K ﹤0.01%
8,704
-582
-6% -$11.9K
SMDV icon
1196
ProShares Russell 2000 Dividend Growers ETF
SMDV
$703M
$199K ﹤0.01%
3,475
-1,200
-26% -$64.6K
PASG icon
1197
Passage Bio
PASG
$14.6M
$197K ﹤0.01%
387
– –
KNX icon
1198
Knight Transportation
KNX
$11.2B
$196K ﹤0.01%
4,704
-1,298
-22% -$52.9K
MDYG icon
1199
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.94B
$195K ﹤0.01%
2,825
– –
SCHA icon
1200
Schwab U.S Small- Cap ETF
SCHA
$23B
$195K ﹤0.01%
8,768
+92
+1% +$1.83K
46 47
48
49 50

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.

  • Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
  • Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
  • Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
  • Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
  • Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
  • Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
  • Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.